These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26055920)

  • 1. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
    Xu Y; Zhou X; Suehs BT; Hartzema AG; Kahn MG; Moride Y; Sauer BC; Liu Q; Moll K; Pasquale MK; Nair VP; Bate A
    Drug Saf; 2015 Aug; 38(8):749-65. PubMed ID: 26055920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
    Zhou X; Murugesan S; Bhullar H; Liu Q; Cai B; Wentworth C; Bate A
    Drug Saf; 2013 Feb; 36(2):119-34. PubMed ID: 23329543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership.
    FitzHenry F; Resnic FS; Robbins SL; Denton J; Nookala L; Meeker D; Ohno-Machado L; Matheny ME
    Appl Clin Inform; 2015; 6(3):536-47. PubMed ID: 26448797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.
    Yang Y; Zhou X; Gao S; Lin H; Xie Y; Feng Y; Huang K; Zhan S
    Drug Saf; 2018 Jan; 41(1):125-137. PubMed ID: 28815480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common Models, Different Approaches.
    Gagne JJ
    Drug Saf; 2015 Aug; 38(8):683-6. PubMed ID: 26088718
    [No Abstract]   [Full Text] [Related]  

  • 6. Transforming French Electronic Health Records into the Observational Medical Outcome Partnership's Common Data Model: A Feasibility Study.
    Lamer A; Depas N; Doutreligne M; Parrot A; Verloop D; Defebvre MM; Ficheur G; Chazard E; Beuscart JB
    Appl Clin Inform; 2020 Jan; 11(1):13-22. PubMed ID: 31914471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database.
    Mott K; Graham DJ; Toh S; Gagne JJ; Levenson M; Ma Y; Reichman ME
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1023-32. PubMed ID: 27146123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children.
    Candore G; Hedenmalm K; Slattery J; Cave A; Kurz X; Arlett P
    Clin Pharmacol Ther; 2020 Apr; 107(4):915-925. PubMed ID: 31956997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMs.
    Liyanage H; Liaw ST; Jonnagaddala J; Hinton W; de Lusignan S
    Stud Health Technol Inform; 2018; 255():60-64. PubMed ID: 30306907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design considerations, architecture, and use of the Mini-Sentinel distributed data system.
    Curtis LH; Weiner MG; Boudreau DM; Cooper WO; Daniel GW; Nair VP; Raebel MA; Beaulieu NU; Rosofsky R; Woodworth TS; Brown JS
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():23-31. PubMed ID: 22262590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of OMOP CDM, i2b2 and ICGC ARGO for supporting data harmonization in a breast cancer use case of a multicentric European AI project.
    Frid S; Bracons Cucó G; Gil Rojas J; López-Rueda A; Pastor Duran X; Martínez-Sáez O; Lozano-Rubí R
    J Biomed Inform; 2023 Nov; 147():104505. PubMed ID: 37774908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases.
    Biedermann P; Ong R; Davydov A; Orlova A; Solovyev P; Sun H; Wetherill G; Brand M; Didden EM
    BMC Med Res Methodol; 2021 Nov; 21(1):238. PubMed ID: 34727871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
    Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OMOP common data model in Australian primary care data: Building a quality research ready harmonised dataset.
    Ward R; Hallinan CM; Ormiston-Smith D; Chidgey C; Boyle D
    PLoS One; 2024; 19(4):e0301557. PubMed ID: 38635655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an ETL tool for converting the PCORnet CDM into the OMOP CDM to facilitate the COVID-19 data integration.
    Yu Y; Zong N; Wen A; Liu S; Stone DJ; Knaack D; Chamberlain AM; Pfaff E; Gabriel D; Chute CG; Shah N; Jiang G
    J Biomed Inform; 2022 Mar; 127():104002. PubMed ID: 35077901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming Anesthesia Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study.
    Lamer A; Abou-Arab O; Bourgeois A; Parrot A; Popoff B; Beuscart JB; Tavernier B; Moussa MD
    J Med Internet Res; 2021 Oct; 23(10):e29259. PubMed ID: 34714250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of CPRD AURUM Data into the OMOP Common Data Model.
    Mayer CS
    Inform Med Unlocked; 2023; 43():. PubMed ID: 38046363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential of OMOP common data model for process mining in healthcare.
    Park K; Cho M; Song M; Yoo S; Baek H; Kim S; Kim K
    PLoS One; 2023; 18(1):e0279641. PubMed ID: 36595527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benefits of large healthcare databases for drug risk research].
    Garbe E; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).
    Hauben M; Aronson JK; Ferner RE
    Drug Saf; 2016 May; 39(5):421-32. PubMed ID: 26879560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.